Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > QD Vision’s Quantum LightTM Product Platform Drives Expansion in First Half of 2008

Abstract:
Developer of Nanotech-based Products Ramps up with Round of Funding, Key Hires, New Contracts and Facilities Expansion

QD Vision’s Quantum LightTM Product Platform Drives Expansion in First Half of 2008

WATERTOWN, MA | Posted on August 11th, 2008

QD Vision, developer of nanotechnology-based solutions for displays and lighting, experienced significant growth in the first half of 2008, driven by increased momentum behind its Quantum Light™ product platform.

Marking its transition from early stage development to a product company, QD Vision raised a $9 million round of venture-capital financing, initiated a multi-million-dollar development deal with In-Q-Tel, strengthened its intellectual and management capital by adding key personnel, and doubled the size of its facilities.

Also in the first half of 2008, four new U.S. patents issued from applications that were included in the patent rights in the nanotechnology field licensed to QD Vision by Massachusetts Institute of Technology (MIT).

The company also continued to design its Quantum Light™ product platform into new products being developed by strategic partners, including some of the largest firms in consumer electronics, flat-panel displays, and electronic signage.

"We are making great progress in our mission to deliver light emitting products and technology that will enable significantly improved color quality, efficiency and designs for next generation displays and lighting applications," said Dr. Dan Button, QD Vision CEO. "The combination of a new round of financing, new government contracts and ongoing work to design the Quantum Light™ lighting product platform into products being developed by some of the largest consumer companies is a clear indication of the company's momentum"

Key Personnel

Joining QD Vision is Dr. Sridhar Sadasivan, director of product development, and Dr. Anne Marie Baker, government program manager. Dr. Sadasivan, who will play a key role in bringing QD Vision's products to market, joins the company from Rohm and Haas, where he was director of product management for optical display films. He also has more than 10 years of experience with Eastman Kodak, where his responsibilities included senior manager for product development, and program manager for optical display films.

Dr. Baker is responsible for growing and managing QD Vision's government-funded development programs. She joins QD Vision from the technology transfer office at the University of Massachusetts, Lowell, where she focused on federal contract grant management, and sponsored research and licensing agreements. Previous experience includes director of R&D at Tyco Adhesives, and R&D positions with Polaroid Corp., Avery Dennison and W.R. Grace.

Expansion

QD Vision now occupies nearly 15,000 square feet of space at its Watertown, Massachusetts location, an increase of more than 80 percent. Much of the new space is dedicated to research and development, testing and pilot manufacturing.

The company expects to more than double its total number of employees from 15 at the beginning of 2008 to nearly 40 by the end of the year. QD Vision currently has 27 employees, having already doubled its technical staff in 2008.

Financing and In-Q-Tel Agreement

In April 2008, QD Vision announced it raised $9 million from two leading venture capital firms, Highland Capital Partners and North Bridge Venture Partners, and from In-Q-Tel, the strategic investment firm launched by the CIA in 1999. The funding will help it launch the first QD Vision Quantum Light™ lighting products into commercial markets. The company has now raised a total of more than $20 million in equity financing.

Highland Capital and North Bridge Venture Partners participated in all rounds of the company's financing, while In-Q-Tel is a new investor. The In-Q-Tel strategic investment included a technology advancement agreement with QD Vision to develop leading edge applications for the commercial and government markets.

QD Vision is perfecting the light-emitting qualities of a new class of nanomaterials called quantum dots. Using proprietary chemistry and process technology, QD Vision can engineer quantum dots to emit light spanning the complete spectrum of colors from the visible to the infrared when stimulated with photons or electrons. Leveraging an expanding patent portfolio, the company is enabling a new generation of practical lighting solutions that will set new standards for brightness, color precision and purity, power consumption and design flexibility.

####

About QD Vision, Inc.
QD Vision (www.qdvision.com) is a quantum-dot product company that delivers highly differentiated lighting solutions to major industries where color, power and design matter. QD Vision’s Quantum Light™ product platform enables step-change advances over other display and lighting solutions such as liquid-crystal displays (LCDs), plasma displays, light-emitting diodes (LEDs), and even organic LEDs (OLEDs). QD Vision is actively designing in products with industry-leading companies in target markets including consumer electronics and flat panel displays, electronic signage, solid state lighting, and defense. Leveraging a first-tier patent position in nanotechnology originating at MIT, QD Vision is a privately held company based in the Watertown, Mass.

For more information, please click here

Contacts:
QD Vision
Dr. Daniel Button
617-607-9726

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Display technology/LEDs/SS Lighting/OLEDs

Enhancing electron transfer for highly efficient upconversion: OLEDs Researchers elucidate the mechanisms of electron transfer in upconversion organic light-emitting diodes, resulting in improved efficiency August 16th, 2024

Efficient and stable hybrid perovskite-organic light-emitting diodes with external quantum efficiency exceeding 40 per cent July 5th, 2024

New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024

Utilizing palladium for addressing contact issues of buried oxide thin film transistors April 5th, 2024

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Appointments/Promotions/New hires/Resignations/Deaths

The National Space Society Mourns the Passing of Robert Krone, Founder of the Kepler Space Institute: Krone's Visionary and Humanistic Approach to the Study of Space Communities and Settlement Was Unique September 22nd, 2021

Leibniz Prize winner Professor Dr. Oliver G. Schmidt moves to Chemnitz University of Technology: President Professor Dr. Gerd Strohmeier refers to an 'absolute top transfer' September 10th, 2021

JEOL USA Welcomes New Managing Director, Hidetaka Sawada April 19th, 2021

The National Space Society Remembers Ben Bova : NSS Mourns the Loss of a Visionary NSS Leader December 2nd, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project